GERBER® Soothe Colic Drops Probiotic Supplement

GERBER® Soothe™ Colic Drops

Introducing GERBER® Soothe Colic Drops for breastfed babies with excessive crying and colic.* Only GERBER® Soothe Colic Drops feature Lactobacillus reuteri (L. reuteri), a probiotic clinically proven to reduce crying time by 50% in colicky, breastfed babies.1-3

GERBER® Soothe Colic Drops Product Information
  • Clinically shown to promote a healthy microbiota1
  • Safe and well tolerated4-5
  • Convenient and easy to use—5 drops per day = 1x108 CFU L. reuteri
  • Each bottle contains a 25-day supply

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
CFU=colony forming units.

 

References:

  1. Savino F et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126:e526-e533.
  2. Savino F et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007;119:e124-e130.
  3. Szajewska H et al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;162:257-262.
  4. Weizman Z et al. Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study. J Am Coll Nutr. 2006;25:415-419.
  5. Connolly E et al. Safety of D–lactic acid producing bacteria in the human infant. J Pediatr Gastroenterol Nutr. 2005;41:489-492.

 

GERBER® Soothe Colic Drops

INGREDIENTS: LACTOBACILLUS REUTERI PROTECTIS® (DSM 17938), SUNFLOWER OIL, MEDIUM CHAIN TRIGLYCERIDE OIL, SILICON DIOXIDE.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References:

  1. Savino F et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126:e526-e533.
  2. Savino F et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007;119:e124-e130.
  3. Szajewska H et al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;162:257-262.
Supplement Facts
Serving Size: 5 Drops
Servings Per Container: 25
Amount Per Serving % Daily Value
Lactobacillus reuteri Protectis® (DSM 17938) 100 MILLION CFU Daily Value not established.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
CFU=colony forming units.

References:

  1. Savino F et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126:e526-e533.
  2. Savino F et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007;119:e124-e130.
  3. Szajewska H et al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;162:257-262.

 

The content on this site is for educational purposes only and is intended solely for medical professionals in the United States only. If you are not a medical professional, please visit www.gerber.com.

All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland or used with permission.

© 2014 Nestlé. All rights reserved.